Oleanolic Acid, FXR, and Cholestatic Liver Injury
2026-08-29
The reference study links oleanolic acid-induced cholestatic liver injury to impaired FXR-dependent bile acid efflux and disruption of hepatocyte tight junctions. By combining transporter-function assays, structural readouts, and pharmacological intervention, it provides a mechanistic framework for studying how altered bile acid handling contributes to liver toxicity.
PDHA1 Succinylation Links α-KGA to CCA Immune Escape
2026-08-29
The reference study identifies a metabolic–immune circuit in cholangiocarcinoma in which PDHA1 K83 succinylation increases alpha-ketoglutaric acid accumulation, activates macrophage OXGR1–MAPK signaling, and suppresses MHC-II antigen presentation. Its preclinical data further indicate that inhibiting this axis with CPI-613 can improve the response to gemcitabine and cisplatin, providing a mechanistic framework for studying chemotherapy resistance.
Biotin (Vitamin B7, Vitamin H): Lab Reliability
2026-08-28
A scenario-based guide to using Biotin (Vitamin B7, Vitamin H), SKU A8010, in metabolic, viability, proliferation, and protein-labeling workflows. It explains formulation constraints, controls, interpretation risks, and practical vendor-selection criteria for more reproducible laboratory decisions.
WTAP, m6A, and MYC in Acute Myeloid Leukemia
2026-08-28
This study links high Wilms’ tumor 1-associated protein (WTAP) expression with poor prognosis in acute myeloid leukemia and identifies WTAP-dependent m6A regulation of MYC mRNA as a functional mechanism. Its combination of patient profiling, WTAP depletion, transcriptomics, m6A-RIP, and RNA stability analysis provides a useful framework for connecting epitranscriptomic changes with leukemia-cell behavior.
Otilonium Bromide Research Workflows
2026-08-27
Build reproducible antimuscarinic assays with practical guidance for stock preparation, concentration selection, smooth-muscle testing, and neuronal readouts. The workflow also shows how structure-based screening logic can inform assay design without overstating evidence for unrelated antiviral applications.
Sulfaphenazole Restores Perfusion in Skin Injury
2026-08-27
Turner and colleagues show that sulfaphenazole limits pressure- and thermal-injury severity in ischemia–reperfusion-susceptible mice by rapidly restoring local tissue perfusion. The study connects improved blood flow with reduced hypoxia, inflammation, fibrosis, better wound repair, and enhanced antimicrobial activity, supporting vascular dysfunction as a tractable target in ischemic skin injury.
DNase I (RNase-free) for CRC RNA Workflows
2026-08-26
Improve RNA, RT-PCR, and chromatin workflows by removing DNA without introducing ribonuclease risk. This practical guide connects cation-controlled DNase I digestion with assays investigating CAF-driven lactate signaling and oxaliplatin resistance in colorectal cancer.
c-Myc Tag Peptide: An Assay Calibration Framework
2026-08-26
The c-Myc Peptide is more than a competitive reagent: it is a practical control for separating tag-dependent antibody recognition from fusion-protein abundance. This article connects c-Myc tag peptide displacement assays with transcription-factor stability, using IRF3 autophagy research to sharpen experimental interpretation.
Annexin V-APC/7-AAD Apoptosis Kit Workflow
2026-08-25
Build a rapid, dual-parameter workflow that separates viable, apoptotic, late apoptotic, and necrotic populations in a single experiment. This guide connects Annexin V-based cell death profiling with PAD4–NETs cancer research while emphasizing controls, gating, and interpretation limits.
Palbociclib in Patient-Derived Assembloids
2026-08-25
Learn how Palbociclib (PD0332991) converts patient-derived gastric cancer assembloids into a functional platform for studying stromal protection, cell-cycle arrest, and treatment resistance. This workflow combines matched organoids, tumor-derived stromal subsets, quantitative readouts, and practical troubleshooting for translational cancer research.
11β-HSD1 Inhibition Rewires Fibrosis Control
2026-08-24
A 2025 mouse study identifies a mechanistic link between 11β-HSD1 activity, intracellular cortisol, Notch signaling, and natural killer cell-mediated clearance of activated hepatic stellate cells. Its findings suggest that metabolic glucocorticoid regulation can influence both fibrogenic signaling and immune surveillance, while also highlighting the limits of extrapolating results from a thioacetamide-induced model.
mCherry mRNA: Workflow, Uses, and Troubleshooting
2026-08-23
EZ Cap™ mCherry mRNA combines Cap 1 capping, 5mCTP and ψUTP, and an approximately 100-nucleotide poly(A) tail for robust transient fluorescent protein expression. This guide translates the reagent into practical workflows for cell imaging, reporter assays, and nanoparticle formulation studies, with controls that separate delivery, stability, translation, and fluorescence effects.
Regorafenib: Melanoma Assay Workflows
2026-08-22
Build mechanism-led melanoma, angiogenesis, and migration studies with Regorafenib (BAY 73-4506), a multikinase inhibitor that connects receptor signaling to RRM2 and ERK/E2F3 biology. This guide combines practical dosing, orthogonal readouts, tumor-model planning, and troubleshooting for more interpretable oncology experiments.
H 89 2HCl: PKA Inhibition and Neural Signaling
2026-08-21
H 89 2HCl is a potent PKA inhibitor used to interrogate cAMP-dependent protein kinase inhibition and protein phosphorylation modulation. Its neuronal use is informative but concentration-dependent off-target kinase activity requires orthogonal controls.
EZ Cap™ Cas9 mRNA (m1Ψ) for CRISPR Editing
2026-08-20
EZ Cap™ Cas9 mRNA (m1Ψ) is an in vitro transcribed Cas9 expression reagent featuring a Cap1 structure, m1Ψ modification, and poly(A) tail. These design elements support mRNA stability and translation efficiency, while the product remains a research-use component that does not independently guarantee editing specificity.
462 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page